New capacity to fuel growth in international market for Rallis Rallis has been expanding its capacity in Metribuzin, which is considered one of the major revenue contributors in the company's international market. The management highlighted that dicamba and glyphosate have some resistance issue, which translates into better volume growth outlook for Rallis since it holds 12% global Metribuzin market share. Further, the CRAMS business has also been witnessing decent growth, which can aid overall growth in the years to come....